Thymic Surgery for Neoplasm: Perspectives on the Optimal Approach.
Matthew Skovgard1, Bernard Park2
1University of California, San Francisco, San Francisco, California.
Seminars in Thoracic and Cardiovascular Surgery
|December 28, 2025
Summary
Surgical strategies for thymic epithelial tumors (TETs) are evolving. Minimally invasive approaches offer benefits for early stages, while advanced stages require complex resections and multimodal therapy for optimal outcomes.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Oncology
Background:
- Thymic epithelial tumors (TETs) present diverse clinical challenges.
- Tailored surgical strategies are essential for optimizing patient outcomes.
- Current evidence synthesis is needed to guide surgical decision-making.
Purpose of the Study:
- To review and synthesize current evidence on surgical approaches for thymic epithelial tumors (TETs).
- To emphasize the roles of tumor stage, anatomy, and multidisciplinary planning in surgical strategy.
- To discuss evolving techniques and future research directions in TET surgery.
Main Methods:
- Systematic review of current evidence on surgical approaches for TETs.
- Emphasis on tumor staging, anatomical considerations, and multidisciplinary planning.
- Analysis of outcomes for minimally invasive versus open surgery and multimodal therapies.
Main Results:
- Minimally invasive techniques (VATS, robotic) show comparable oncologic outcomes to open surgery for early-stage TETs (Stage I/II), with improved recovery.
- Robotic thymectomy offers advantages in reduced blood loss and complications.
- Locally advanced tumors (Stage IIIA-B) and Stage IVA disease require complex resections and often multimodal therapy, with individualized management crucial.
Conclusions:
- Surgical management of TETs is advancing, integrating minimally invasive techniques and multimodal therapies.
- R0 resection remains the priority, with ongoing debates regarding lymphadenectomy and partial thymectomy.
- High-volume centers and international collaboration are vital for rare malignancies like TETs, necessitating further prospective research.


